Test Price
2,800 AED✅ Home Collection Available
TPM2 Gene Nemaline Myopathy Type 4 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين TPM2 لاعتلال العضلات الخيطي من النوع الرابع في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary | الملخص التنفيذي
نقدم تحليلًا جينيًا موثوقًا لتشخيص اعتلال العضلات الخيطي من النوع الرابع مع استشارة وراثية معتمدة، وفق أعلى معايير الجودة.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in Result Interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview
English: This comprehensive Next‑Generation Sequencing (NGS) test analyses the entire TPM2 gene to detect pathogenic variants linked to nemaline myopathy type 4, a congenital neuromuscular disorder characterised by muscle weakness and hypotonia. It is the definitive genetic test for diagnosing this rare condition.
العربية: تحليل شامل بتقنية التسلسل الجيني من الجيل التالي (NGS) يفحص كامل جين TPM2 للكشف عن الطفرات المسببة لاعتلال العضلات الخيطي من النوع الرابع، وهو مرض عضلي وراثي نادر.
| Feature | Our Test (DNA Labs UAE) | Closest Alternative |
|---|---|---|
| Methodology | Comprehensive NGS (full gene + CNV) – CE‑marked, ISO 9001:2015 | Single‑gene Sanger sequencing (limited to small variants) |
| Turnaround Time | 3–4 Weeks (Rapid reporting available) | 6–8 Weeks |
| Sample Types | Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card) | Whole Blood only |
| UAE Home Collection | 8 AM – 11 PM, 7 days a week | Limited or no service |
| Post‑Test Clinical Call | Included with board‑certified genetic counsellor | Not included |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY, Clinical Pathologist (DHA Licence: 61713011)
“This test detects pathogenic variants in the TPM2 gene with high precision; however, a negative result does not exclude nemaline myopathy if clinical symptoms are strongly suggestive. I always recommend correlating with muscle biopsy, EMG, and a detailed family history for a complete diagnosis. Please use this report as one piece of your comprehensive clinical assessment.”
⚠️ Medication Warning
Do not discontinue any prescribed medication or alter your treatment plan without consulting your treating physician. Genetic test results must be interpreted within the full clinical context.
🧬 Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Patients with acute bleeding disorders or those on high‑dose anticoagulants may require a specialist‑supervised blood draw. Neonates: minimum 250 µL whole blood on FTA card required.
- Emergency Red Flags: If you or your child develop sudden severe muscle weakness, swallowing difficulties, respiratory distress, or cardiac arrhythmia, seek immediate emergency medical attention – do not wait for test results.
Patient FAQ & Clinical Guidance
What is the TPM2 gene nemaline myopathy type 4 NGS test?
Quick Answer: It is a genetic test that sequences the entire TPM2 gene to identify mutations causing nemaline myopathy type 4, a congenital muscle disorder.
The test uses Next‑Generation Sequencing to detect even rare variants, helping confirm a clinical diagnosis, guide treatment, and inform family planning.
بالعربية: هو اختبار جيني يحدد الطفرات في جين TPM2 المسببة لاعتلال العضلات الخيطي من النوع الرابع باستخدام تقنية التسلسل من الجيل التالي.
Who should consider this genetic test?
Quick Answer: Individuals with clinical features like infantile hypotonia, muscle weakness, delayed motor milestones, or a family history of nemaline myopathy should consider testing.
It is also recommended for asymptomatic siblings when a family mutation is known, and for genetic counselling prior to pregnancy.
بالعربية: ينصح بهذا الفحص للأفراد الذين تظهر عليهم أعراض ضعف العضلات وتأخر الحركة، أو لمن لديهم تاريخ عائلي للمرض.
What do my test results mean?
Quick Answer: A positive result confirms the diagnosis and enables targeted management; a negative result reduces the likelihood of TPM2‑related nemaline myopathy but does not exclude other genetic causes.
All results include a detailed clinical interpretation by our geneticists, and a post‑test teleconsultation is provided to answer your questions.
بالعربية: النتيجة الإيجابية تؤكد التشخيص وتوجه العلاج. النتيجة السلبية تقلل الاحتمال ولكنها لا تنفي الأسباب الجينية الأخرى تمامًا.
UAE Regulatory Compliance
This is performed in accordance with Federal Decree‑Law No. 41 of 2024 (Art. 87), UAE CDS Law 2026 for minors, and the UAE Personal Data Protection Law (PDPL). All genetic data is encrypted and stored within UAE borders.
Booking & Support: Call or WhatsApp +971 54 548 8731 (Home Collection 8 AM – 11 PM). Facility Licence: 9834453. ISO 9001:2015 Cert: INT/EGQ/2509DA/3139.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians